← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nerx Biosciences, Inc.
Indianapolis, IN
$3,553,129
Total funding
6
Grants
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,553,129 · 6
By mechanism
R44$2,000,000 · 1
R43$892,927 · 3
R41$660,202 · 2
Investigators at Nerx Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy$1,078,680
R44 · FY2024 · CA
Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy$921,320
R44 · FY2025 · CA
Development of novel Ku targeted kinase inhibitors$300,000
R43 · FY2017 · CA
Targeting the ERCC1/XPF nuclease for cancer therapy$299,922
R43 · FY2012 · CA
Chemical enhancement of CRISPR/Cas9 mediated site-specific genome engineering$293,005
R43 · FY2016 · GM
Development of novel lung cancer therapeutics targeting the DNA damage response$249,431
R41 · FY2015 · CA
Development of Novel Agents Targeting Genome Stability and Maintenance for Treati$229,680
R41 · FY2012 · CA
Development of Novel Agents Targeting Genome Stability and Maintenance for Treati$131,247
R41 · FY2013 · CA
A new generation of targeted therapeutics for the treatment of cancer.$49,844
R41 · FY2017 · CA